Gene Targeting to the Cerebral Cortex Following Intranasal Administration of Polyplexes
Open Access
- 26 May 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (6) , 1136
Abstract
Gene delivery to the cerebral cortex is challenging due to the blood brain barrier and the labile and macromolecular nature of DNA. Here we report gene delivery to the cortex using a glycol chitosan—DNA polyplex (GCP). In vitro, GCPs carrying a reporter plasmid DNA showed approximately 60% of the transfection efficiency shown by Lipofectamine lipoplexes (LX) in the U87 glioma cell line. Aiming to maximise penetration through the brain extracellular space, GCPs were coated with hyaluronidase (HYD) to form hyaluronidase-coated polyplexes (GCPH). The GCPH formulation retained approximately 50% of the in vitro hyaluronic acid (HA) digestion potential but lost its transfection potential in two-dimensional U87 cell lines. However, intranasally administered GCPH (0.067 mg kg−1 DNA) showed high levels of gene expression (IVIS imaging of protein expression) in the brain regions. In a separate experiment, involving GCP, LX and naked DNA, the intranasal administration of the GCP formulation (0.2 mg kg−1 DNA) resulted in protein expression predominantly in the cerebral cortex, while a similar dose of intranasal naked DNA led to protein expression in the cerebellum. Intranasal LX formulations did not show any evidence of protein expression. GCPs may provide a means to target protein expression to the cerebral cortex via the intranasal route.Keywords
Funding Information
- EPSRC (EP/L01646X/1, award # 1638294)
- Centre for Doctoral Training in Targeted Therapeutics and Nanomedicines at the UCL School of Pharmacy (EP/L01646X/1, award # 1638294)
This publication has 69 references indexed in Scilit:
- Intranasal Treatment of Central Nervous System Dysfunction in HumansPharmaceutical Research, 2012
- Intranasal Delivery of HMGB1 siRNA Confers Target Gene Knockdown and Robust Neuroprotection in the Postischemic BrainMolecular Therapy, 2012
- The extracellular matrix at a glanceJournal of Cell Science, 2010
- N-Acetylglucosamine: Production and ApplicationsMarine Drugs, 2010
- Nanomaterial cytotoxicity is composition, size, and cell type dependentParticle and Fibre Toxicology, 2010
- Intranasal delivery to the central nervous system: Mechanisms and experimental considerationsJournal of Pharmaceutical Sciences, 2010
- New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163Neuro-Oncology, 2008
- Pharmaceutical nanotechnology: polymeric vesicles for drug and gene deliveryExpert Opinion on Drug Delivery, 2006
- The “Perivascular Pump” Driven by Arterial Pulsation Is a Powerful Mechanism for the Distribution of Therapeutic Molecules within the BrainMolecular Therapy, 2006
- Controls on Polymer Molecular Weight May Be Used To Control the Size of Palmitoyl Glycol Chitosan Polymeric VesiclesLangmuir, 2001